FDA issues urgent warning about this supplement that contains a hidden prescription drug

Be careful before you reach for that supplement in your medicine cabinet. Primal Supplements Group LLC of Albuquerque, New Mexico, is voluntarily recalling all orders of its Primal Herbs Volume dietary supplement after FDA testing confirmed the product contains sildenafil,

Viagra drug found in ‘wellness’ supplement prompts nationwide recall

A New Mexico-based company is recalling one of its supplements after a lab found it to contain the erectile dysfunction drug sildenafil, according to a Wednesday news release from the Food and Drug Administration (FDA).
STAT

The FDA is targeting telehealth marketing of GLP-1 drugs. Who’s prescribing them?

The FDA is targeting telehealth marketing of GLP-1 drugs. But those companies may not be the only ones under the microscope.
Yahoo

FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs

Add Yahoo as a preferred source to see more of our stories on Google. Nitrosamines are by-products of many common chemical reactions. FatCamera/iStock via Getty Images Plus A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is ...
The Hill

FDA to streamline approvals of generic biologic drugs

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The agency published a draft guidance for ...
CNN

FDA’s top drug officer set to exit, weeks into new role

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was chosen to lead the FDA’s drug division, according to four people familiar with his decision. Dr. Richard Pazdur was named director ...
Monthly Prescribing Reference

FDA to Ease Copycat Drug Rules, Speeding Access to Cheaper Drugs

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness. HealthDay News — The US Food and Drug Administration (FDA) announced Wednesday that it ...
ProPublica

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors who worked on this story. It’s a fundamental tenet of ...

FDA Plans to Loosen Testing Rules to Boost Biosimilar Drugs

The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic medications in a bid to bring more competition to the market and lower costs.